Quadrant Capital Group LLC Vericel Corp Transaction History
Quadrant Capital Group LLC
- $2.65 Billion
- Q1 2025
A detailed history of Quadrant Capital Group LLC transactions in Vericel Corp stock. As of the latest transaction made, Quadrant Capital Group LLC holds 9,948 shares of VCEL stock, worth $418,014. This represents 0.02% of its overall portfolio holdings.
Number of Shares
9,948
Previous 291
3318.56%
Holding current value
$418,014
Previous $15,000
2853.33%
% of portfolio
0.02%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding VCEL
# of Institutions
291Shares Held
52.1MCall Options Held
36.7KPut Options Held
6.4K-
Black Rock Inc. New York, NY8.06MShares$339 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$147 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.88MShares$121 Million3.98% of portfolio
-
State Street Corp Boston, MA2.44MShares$102 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.27MShares$95.5 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.98B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...